Skip to main content
Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
1.400
-0.070 (-4.76%)
At close: Jul 19, 2024, 4:00 PM
1.390
-0.010 (-0.71%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

Barinthus Biotherapeutics Revenue

Barinthus Biotherapeutics had revenue of $334.00K in the twelve months ending March 31, 2024. In the year 2023, Barinthus Biotherapeutics had annual revenue of $802.00K.

Revenue (ttm)
$334.00K
Revenue Growth
-98.89%
P/S Ratio
163.28
Revenue / Employee
$2,569
Employees
130
Market Cap
54.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023802.00K-43.90M-98.21%
Dec 31, 202244.70M44.44M16,580.22%
Dec 31, 2021268.00K-4.55M-94.44%
Dec 31, 20204.82M-2.02M-29.57%
Dec 31, 20196.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Allurion Technologies 48.78M
Cidara Therapeutics 46.38M
Atara Biotherapeutics 34.70M
Turnstone Biologics 19.31M
Ocuphire Pharma 19.01M
LAVA Therapeutics 13.63M
Revenue Rankings

BRNS News

More News